Accessibility Menu
Merck KGaA logo

Merck KGaA(OTC) MKKGY

Current Price$31.64
Market Cap$20.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)+224%
5 Year-17%
1 Year+20%
1 Month-1%
Merck KGaA last closing stock price
MetricPriceDate
Last closeUSD 31.642026-07-24
Merck KGaA stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.56%USD 31.152026-07-17
1 month-0.68%USD 31.852026-06-24
3 month+22.57%USD 25.812026-04-24
Year to date+12.53%USD 28.112025-12-31
1 year+20.38%USD 26.282025-07-24
3 year-3.93%USD 32.932023-07-25
5 year-16.69%USD 37.972021-07-23
Since inception+224.16%USD 9.762007-11-13

Merck KGaA Financials at a Glance

Market Cap

$20.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€20.91B

Net Income (TTM)

€2.53B

EPS (TTM)

$1.35

P/E Ratio

23.43

Dividend

$0.51

Beta (Volatility)

0.73 (Low)

Price

$31.64

Volume

41,656

Open

$31.96

Previous Close

$31.64

Daily Range

$31.64 - $31.98

52-Week Range

$23.73 - $34.19

Estimated Earnings Date

Aug 6, 2026

MKKGY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Merck KGaA

Merck KGaA is a prominent German science and technology company, operating in three main sectors: Life Science, Healthcare, and Electronics. With a rich history dating back to 1668, the company is headquartered in Darmstadt, Germany, and is recognized for its innovative solutions across various industries.

Products and Services
  • Life Science division offers tools, chemicals, and equipment for research and industrial applications
  • Healthcare segment focuses on prescription drugs and biopharmaceuticals across multiple therapeutic areas
  • Electronics division supplies materials for semiconductor and display industries, including innovative surface products
Growth Outlook
  • Recent quarterly revenue reached €5.13 billion, showcasing strong market demand
  • Operating income margin improved to 18.4% in Q1 2026, indicating operational efficiency
  • Strategic collaborations enhance product pipeline and market reach, driving future growth
Financial Highlights
  • Trailing twelve-month revenue of €20.5 billion reflects consistent performance
  • Net income for Q1 2026 was €659 million, demonstrating profitability
  • Dividend yield stands at 1.58%, providing a return to shareholders
AI Generated • Jul 24, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

62,477

CEO

Belén Garijo López, MD

Website

www.merckgroup.com

Headquarters

Darmstadt, HE 64293, DE

MKKGY Financials

Key Financial Metrics (TTM)

Gross Margin

58.53%

Operating Margin

19.41%

Net Income Margin

12.09%

Return on Equity

8.77%

Return on Capital

9.63%

Return on Assets

4.77%

Earnings Yield

4.27%

Dividend Yield

1.63%

Payout Ratio

11.76%

Stock Overview

Market Cap

$20.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

646.21M

Volume

41.66K

Avg. Volume

78.20K

Financials (TTM)

Gross Profit

€12.24B

Operating Income

€3.83B

EBITDA

€6.22B

Operating Cash Flow

€4.16B

Capital Expenditure

-€1.86B

Free Cash Flow

€2.30B

Cash & ST Invst.

€3.77B

Total Debt

€12.05B

Merck KGaA Performance Analysis

Merck KGaA annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 23,365,261,0070.4%
20232023-12-31EUR 22,695,859,854-2.9%
20242024-12-31EUR 22,884,249,6410.8%
20252025-12-31EUR 23,815,251,9134.1%
Merck KGaA sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-0.5%
Q32025-09-301.2%
Q42025-12-31-2.2%
Q12026-03-31-1.3%
Merck KGaA annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.61-3.2%
20232023-12-31EUR 1.40-12.7%
20242024-12-31EUR 1.38-1.6%
20252025-12-31EUR 1.35-2.0%
Merck KGaA sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-11.2%
Q32025-09-3036.7%
Q42025-12-31-64.9%
Q12026-03-31108.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€5.13B

-2.8%

Gross Profit

€3.07B

-2.5%

Gross Margin

59.70%

N/A

Market Cap

$20.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$327.29K

N/A

Employees

62,461

N/A

Net Income

€659.00M

-10.3%

EBITDA

€1.47B

-2.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€3.77B

+133.0%

Total Debt

€12.05B

+28.3%

Accounts Receivable

€4.44B

-0.7%

Inventory

€4.78B

+6.0%

Long Term Debt

€10.81B

+43.7%

Short Term Debt

€1.24B

-28.6%

Return on Assets

4.77%

N/A

Return on Invested Capital

9.30%

N/A

Free Cash Flow

€272.00M

+750.0%

Operating Cash Flow

€818.00M

+47.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DSKYFDaiichi Sankyo Company, Limited
$15.95-8.96%
DSNKYDaiichi Sankyo Company, Limited
$17.25+1.41%
CMXHFCSL Limited
$81.96+0.00%
CHALFChalice Brands Ltd
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About MKKGY

What is the current price of Merck KGaA?

Merck KGaA is trading at $31.64 per share.

What is the 52-week range for Merck KGaA?

Over the past 52 weeks, Merck KGaA has traded between $23.73 and $34.19.

How much debt does Merck KGaA have?

As of the most recent reporting period, Merck KGaA reported total debt of €13.87B.

How much cash does Merck KGaA have on hand?

Merck KGaA reported €3.16B in cash and cash equivalents in its most recent financial results.

What is Merck KGaA’s dividend yield?

Merck KGaA currently has a dividend yield of 1.63%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services